Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

This article (A59434) is a billing and coding guidance document that refers to LCD L39624 for coverage of amniotic and placental-derived product injections and applications for musculoskeletal, non-wound indications. The provided text does not include the LCD's specific coverage indications, limitations, documentation requirements, or frequency limits; review of LCD L39624 is required to extract actionable criteria.

"This billing and coding article references Local Coverage Determination LCD L39624 for coverage and documentation requirements for amniotic and placental-derived product injections/applications for..."

Sign up to see full coverage criteria, indications, and limitations.